Schizophrenia and Disorders with Psychotic Features
Welcome,         Profile    Billing    Logout  
 86 Companies   134 Products   134 Products   85 Mechanisms of Action   5 Trials   1881 News 


«12345678910111213...3738»
  • ||||||||||  Trial primary completion date:  Social Cognition Training in Schizophrenia (clinicaltrials.gov) -  Mar 30, 2016   
    P=N/A,  N=25, Recruiting, 
    Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  Enrollment open:  Home Treatment for Acute Psychiatric Care (clinicaltrials.gov) -  Mar 29, 2016   
    P=N/A,  N=500, Recruiting, 
    Trial primary completion date: Dec 2016 --> Jun 2017 Not yet recruiting --> Recruiting
  • ||||||||||  Trial primary completion date:  Healthy Bodies, Healthy Kids (clinicaltrials.gov) -  Mar 24, 2016   
    P=N/A,  N=126, Recruiting, 
    Trial primary completion date: Jan 2016 --> Jun 2016 Trial primary completion date: Oct 2015 --> Dec 2016
  • ||||||||||  Trial primary completion date:  Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder (clinicaltrials.gov) -  Mar 23, 2016   
    P=N/A,  N=300, Recruiting, 
    Trial primary completion date: Oct 2015 --> Dec 2016 Trial primary completion date: Dec 2015 --> Jun 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  The Partners Genetics Collaborative Study of Schizophrenia (clinicaltrials.gov) -  Mar 19, 2016   
    P=N/A,  N=500, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Oct 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Oct 2016
  • ||||||||||  Kuvan (sapropterin) / Merck (MSD), BioMarin, Daiichi Sankyo
    Trial primary completion date:  Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) -  Mar 19, 2016   
    P1/2,  N=60, Suspended, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Oct 2016 Trial primary completion date: Feb 2016 --> Jun 2016
  • ||||||||||  olanzapine / Generic mfg., sertraline / Generic mfg.
    Trial primary completion date:  STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) -  Mar 19, 2016   
    P4,  N=392, Recruiting, 
    Trial primary completion date: Feb 2016 --> Jun 2016 Trial primary completion date: Mar 2017 --> Aug 2017
  • ||||||||||  carbidopa/levodopa / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) -  Mar 15, 2016   
    P2,  N=13, Completed, 
    Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=24 --> 13 | Trial primary completion date: Sep 2016 --> Dec 2015
  • ||||||||||  Trial completion:  Supported Employment: Motivational Enhancement for Entry and Outcome (clinicaltrials.gov) -  Mar 9, 2016   
    P2,  N=168, Completed, 
    Recruiting --> Completed | N=30 --> 21 | Trial primary completion date: Aug 2016 --> Feb 2016 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  Mental Health Engagement Network (MHEN) (clinicaltrials.gov) -  Mar 8, 2016   
    P=N/A,  N=400, Completed, 
    Active, not recruiting --> Completed Not yet recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
  • ||||||||||  Trial primary completion date:  Microfinance Intervention to Improve Health of Trauma Survivors in DRC (clinicaltrials.gov) -  Feb 29, 2016   
    P=N/A,  N=878, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> May 2016 Trial primary completion date: Dec 2015 --> Apr 2016
  • ||||||||||  Trial completion:  Trial of D-Cycloserine in Schizophrenia (clinicaltrials.gov) -  Feb 27, 2016   
    P3,  N=60, Completed, 
    Recruiting --> Completed No longer recruiting --> Completed
  • ||||||||||  Trial primary completion date, Adverse events:  Monitoring and Management for Metabolic Side Effects of Antipsychotics (clinicaltrials.gov) -  Feb 25, 2016   
    P=N/A,  N=103, Active, not recruiting, 
    No longer recruiting --> Completed Trial primary completion date: Dec 2014 --> Mar 2016
  • ||||||||||  Trial completion, Enrollment change:  Oxytocin as Adjunctive Therapy for Schizophrenia (clinicaltrials.gov) -  Feb 24, 2016   
    P2,  N=32, Completed, 
    Trial primary completion date: Dec 2014 --> Mar 2016 Active, not recruiting --> Completed | N=80 --> 32
  • ||||||||||  Trial completion, Adherence:  Effectiveness of Adherence Therapy for Schizophrenia (clinicaltrials.gov) -  Feb 21, 2016   
    P1/2,  N=134, Completed, 
    Recruiting --> Active, not recruiting Active, not recruiting --> Completed
  • ||||||||||  Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes
    Trial primary completion date:  An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) (clinicaltrials.gov) -  Feb 16, 2016   
    P3,  N=300, Enrolling by invitation, 
    Active, not recruiting --> Completed Trial primary completion date: Jan 2016 --> May 2016
  • ||||||||||  aripiprazole / Generic mfg., olanzapine / Generic mfg.
    Enrollment closed, Enrollment change, Trial primary completion date, Adverse events:  Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic (clinicaltrials.gov) -  Feb 10, 2016   
    P4,  N=200, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Jan 2013 --> Jan 2015 Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Illness Management and Recovery (IMR) in Danish Community Mental Health Centres (clinicaltrials.gov) -  Feb 10, 2016   
    P=N/A,  N=198, Completed, 
    Recruiting --> Active, not recruiting | N=340 --> 200 | Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Dec 2013